Clinical trial
Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage…
NCT00003577 · University Hospital Birmingham, Other · Completed
Key facts
| NCT number | NCT00003577 |
|---|---|
| Title | Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer |
| Official title | National Breast Cancer Study of Epirubicin + CMF v Classical CMF Adjuvant Therapy |
| Lead sponsor | University Hospital Birmingham, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | CMF regimen, cyclophosphamide, epirubicin hydrochloride, fluorouracil, methotrexate, adjuvant therapy, radiation therapy |
| Enrollment | 2,000 |
| Start date | Mar 1, 1996 |
| Completion | Sep 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 19, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: